Identification
- Summary
Peach is an extract from Peach used in allergy testing.
- Generic Name
- Peach
- DrugBank Accession Number
- DB10552
- Background
Peach allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- PEACH ALLERGENIC EXTRACT
Pharmacology
- Indication
For the treatment of Pneumococcal pneumonia due to susceptible strains and group A beta-hemolytic streptococcal infections of the upper respiratory tract.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Troleandomycin is a macrolide antibiotic that is similar to erythromycin. It is active in vitro against the following gram-positive organisms: Streptococcus pyogenes and Diplococcus pneumoniae.
- Mechanism of action
Troleandomycin acts by penetrating the bacterial cell membrane and reversibly binding to the 50 S subunit of bacterial ribosomes or near the "P" or donor site so that binding of tRNA (transfer RNA) to the donor site is blocked. Translocation of peptides from the "A" or acceptor site to the "P" or donor site is prevented, and subsequent protein synthesis is inhibited.
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Symptoms of overdose include diarrhea, nausea, stomach cramps, and vomiting.
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Food - Plant Source, Peach Prunus persica Injection, solution 0.1 g/1mL Percutaneous; Subcutaneous Jubilant Hollisterstier Llc 1941-04-19 Not applicable US 
Food - Plant Source, Peach Prunus persica Injection, solution 0.1 g/1mL Percutaneous Jubilant Hollisterstier Llc 1941-04-19 Not applicable US Peach Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Peach Injection, solution 0.10 g/1mL Percutaneous ALK-Abello, Inc. 1998-02-23 Not applicable US Peach Solution 0.025 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3OKE88I3QG
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Percutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 1 mL/1mL Injection, solution Percutaneous 0.10 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Solution Intradermal; Percutaneous; Subcutaneous 0.025 g/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53